- Home
- RVT vs AZTA Comparison
RVT vs AZTA Comparison
Compare RVT & AZTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVT
- AZTA
- Stock Information
- Founded
- RVT 1986
- AZTA 1978
- Country
- RVT United States
- AZTA United States
- Employees
- RVT N/A
- AZTA N/A
- Industry
- RVT Trusts Except Educational Religious and Charitable
- AZTA Industrial Machinery/Components
- Sector
- RVT Finance
- AZTA Technology
- Exchange
- RVT Nasdaq
- AZTA Nasdaq
- Market Cap
- RVT 1.9B
- AZTA 1.8B
- IPO Year
- RVT N/A
- AZTA 1995
- Fundamental
- Price
- RVT $14.43
- AZTA $27.71
- Analyst Decision
- RVT
- AZTA Buy
- Analyst Count
- RVT 0
- AZTA 3
- Target Price
- RVT N/A
- AZTA $50.67
- AVG Volume (30 Days)
- RVT 243.4K
- AZTA 896.2K
- Earning Date
- RVT 01-01-0001
- AZTA 05-07-2025
- Dividend Yield
- RVT 7.32%
- AZTA N/A
- EPS Growth
- RVT N/A
- AZTA N/A
- EPS
- RVT 2.95
- AZTA N/A
- Revenue
- RVT N/A
- AZTA $669,171,000.00
- Revenue This Year
- RVT N/A
- AZTA N/A
- Revenue Next Year
- RVT N/A
- AZTA $5.38
- P/E Ratio
- RVT $4.98
- AZTA N/A
- Revenue Growth
- RVT N/A
- AZTA 4.70
- 52 Week Low
- RVT $11.85
- AZTA $24.06
- 52 Week High
- RVT $14.93
- AZTA $63.58
- Technical
- Relative Strength Index (RSI)
- RVT 58.51
- AZTA 46.72
- Support Level
- RVT $14.01
- AZTA $23.91
- Resistance Level
- RVT $14.41
- AZTA $27.06
- Average True Range (ATR)
- RVT 0.27
- AZTA 1.38
- MACD
- RVT 0.12
- AZTA 0.56
- Stochastic Oscillator
- RVT 93.62
- AZTA 90.69
About RVT Royce Value Trust Inc.
Royce Value Trust Inc is a diversified closed-end investment company. It invests in diversified sectors including consumer discretionary, consumer staples, healthcare, financial, IT, telecommunications, and materials. The company's portfolio includes common stocks, preferred stocks, corporate bonds, and repurchase agreements.
About AZTA Azenta Inc.
Azenta Inc is a provider of life sciences solutions, enabling impactful breakthroughs and therapies to market faster. It provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and advanced cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. The company has two reportable segments that are Life Sciences Products and Life Sciences Services. It generates a substantial part of its revenue from its Life Sciences Services segment.